who are not suitable for surgical or transcatheter edge-to-edge repair treatments. 4C Medical Technologies CEO and president ...
The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback